Pharmaceutical

Moderna mpox mRNA vaccine shows early promise in monkey study

Moderna is currently running a Phase I/II trial of the mRNA mpox vaccine mRNA-1769 in healthy participants.

Sep 6, 2024 - 04:00
Moderna mpox mRNA vaccine shows early promise in monkey study
Moderna is currently running a Phase I/II trial of the mRNA mpox vaccine mRNA-1769 in healthy participants.
Read the original article

Tags:

Previous Article

Lilly partners with Haya for lncRNA obesity target deal worth $1bn

Next Article

eGenesis scoops $191m for genetically modified pig kidney transplant trial

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: FDA flags safety concerns with CRISPR-based sickle cell treatment; FDA warns about eye drop infection risk

STAT+: Pharmalittle: FDA flags safety concerns with CRI...

Oct 30, 2023

Influenza (quadrivalent) vaccine by Pfizer for Influenz...

May 17, 2024

mRNA vaccine for cancer along with Keytruda obtains PRIME designation

mRNA vaccine for cancer along with Keytruda obtains PRI...

Apr 10, 2023